about
Splicing therapy for neuromuscular diseaseHigh expression level of Tra2-β1 is responsible for increased SMN2 exon 7 inclusion in the testis of SMA miceOn the road with WRAP53β: guardian of Cajal bodies and genome integrityMacromolecular transport between the nucleus and the cytoplasm: Advances in mechanism and emerging links to disease.Therapeutic strategies for the treatment of spinal muscular atrophy.SMN-inducing compounds for the treatment of spinal muscular atrophy.Whole-genome screening identifies proteins localized to distinct nuclear bodiesCajal body proteins differentially affect the processing of box C/D scaRNPs.Spinal muscular atrophy: the role of SMN in axonal mRNA regulation.Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy.NUFIP and the HSP90/R2TP chaperone bind the SMN complex and facilitate assembly of U4-specific proteins.Deficiency of the Survival of Motor Neuron Protein Impairs mRNA Localization and Local Translation in the Growth Cone of Motor Neurons.CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease.Coilin association with Box C/D scaRNA suggests a direct role for the Cajal body marker protein in scaRNP biogenesis.Nuclear bodies: multifunctional companions of the genome.Update on gene and stem cell therapy approaches for spinal muscular atrophy.Minor splicing pathway is not minor any more: implications for the pathogenesis of motor neuron diseases.Towards an understanding of regulating Cajal body activity by protein modification.Genome-wide identification of mRNAs associated with the protein SMN whose depletion decreases their axonal localization.Identification of processing elements and interactors implicate SMN, coilin and the pseudogene-encoded coilp1 in telomerase and box C/D scaRNP biogenesis.SMN and coilin negatively regulate dyskerin association with telomerase RNA.The catalytically inactive tyrosine phosphatase HD-PTP/PTPN23 is a novel regulator of SMN complex localization.Analysis of the C9orf72 gene in spinal muscular atrophy patients.Regulation of Skeletal Muscle Plasticity by Protein Arginine Methyltransferases and Their Potential Roles in Neuromuscular Disorders.Lysine-Less Variants of Spinal Muscular Atrophy SMN and SMNΔ7 Proteins Are Degraded by the Proteasome Pathway.A new cis-acting motif is required for the axonal SMN-dependent Anxa2 mRNA localization.Reorganization of Cajal bodies and nucleolar targeting of coilin in motor neurons of type I spinal muscular atrophy.Spinal muscular atrophy within Amish and Mennonite populations: Ancestral haplotypes and natural historyAltered dynamics of scaRNA2 and scaRNA9 in response to stress correlates with disrupted nuclear organizationA new biomarker candidate for spinal muscular atrophy: Identification of a peripheral blood cell population capable of monitoring the level of survival motor neuron protein
P2860
Q27009581-94BE45B4-5CB2-4040-8DC2-9C41781A3EE6Q27311317-CC69B09E-FAFA-4809-B51A-622E2E5773BFQ34043691-A1B35695-20E7-471B-8D75-F71183381DDCQ34169454-C88BEE77-89CD-4FD7-98C0-F2E09CAE8D94Q34296140-7A9CC2E8-F417-4DEF-AB1E-F938ACAAF872Q34312156-36EA6EDE-580A-4028-8CCC-46D3CA7C88B0Q34377737-799DE31F-817A-4523-824F-E420CE482908Q35391951-F5573D39-B621-4BB5-8B81-89E2D90B296AQ35990221-EFA8FA86-0D77-4A4D-95C6-0B54D03A0928Q36061996-63CA840B-80DF-4D76-998D-B8D530BBB16BQ36160639-3A561821-9642-4BDC-AE83-C2509748C3BFQ36740997-EA6CEEFD-B066-4753-919C-89AA695D9BDBQ36831893-8F400E62-2669-49DA-BFDB-3A2226CB0C4AQ37706165-10D8C8A2-6E4A-45D1-944F-727DE810C259Q38006159-11347532-6970-44A2-9FD7-FDB9CF277726Q38030978-FC44D14F-D854-4656-9B07-2D58E10393F4Q38151263-77B94950-4CFE-4120-A4FC-7D1C34368055Q38797923-7CBA8503-843C-42A8-83BC-079E524F30F3Q39072801-01FCB4C8-89EC-4281-AA96-FE81F9DE0C04Q41385010-E6E7B364-1F0A-4D1C-8B7E-A445F30A4E45Q41965772-C3374C6D-ECD8-4179-BFFA-C4FD595D6413Q42540607-61731A48-BA18-4140-9B12-D40936D29F04Q42670584-4136E67B-D12F-4DCD-823C-9D94F52B399BQ47140882-8E892AFA-60D1-4453-99C4-B4538FBEBA4AQ47225050-CBEC4031-A16B-4740-9C01-B1C271CB897AQ47786052-3F933951-B966-4062-A508-A42BF154ADA0Q50517797-77DB079E-1F98-49B4-ABD9-D8AAE93731F9Q58762172-00597DED-6301-41BE-B0FA-BFA16CBAA005Q58766130-A3293C42-246F-45BB-9D76-9BFF32EFE11BQ58787242-0AEFB651-F703-4357-B478-7EBBC35F08A8
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
SMN in spinal muscular atrophy and snRNP biogenesis
@ast
SMN in spinal muscular atrophy and snRNP biogenesis
@en
type
label
SMN in spinal muscular atrophy and snRNP biogenesis
@ast
SMN in spinal muscular atrophy and snRNP biogenesis
@en
prefLabel
SMN in spinal muscular atrophy and snRNP biogenesis
@ast
SMN in spinal muscular atrophy and snRNP biogenesis
@en
P2860
P3181
P356
P1476
SMN in spinal muscular atrophy and snRNP biogenesis
@en
P2093
Christian L. Lorson
Tristan H. Coady
P2860
P304
P3181
P356
10.1002/WRNA.76
P577
2011-02-17T00:00:00Z